HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,250.00
+9.00 (0.73%)
At close: Mar 12, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 103.22 billion as of March 13, 2026. Its market cap has decreased by -43.89% in one year.
Market Cap
103.22B
Enterprise Value
114.53B
Revenue
71.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,250.00
Market Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 103.22B, a decrease of -59.43%. That is a compound annual growth rate of -13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 105.59B | -14.03% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 1.02T |
| DreamCIS | 126.57B |
| P&K Skin Research Center | 62.10B |
| WOOJUNG BIO | 55.62B |
| C&R Research | 46.61B |
| DT&CRO CO. | 39.50B |
| SLS BIO | 26.89B |
| BioInfra | 19.21B |